Becotatug (JMT101) is a humanised monoclonal antibody targeting EGFR, demonstrating antitumour activity when combined with Osimertinib for treating EGFR-mutated advanced NSCLC.
Purity:
99.10%
CAS Number:
[2648260-93-7]
Target:
EGFR
* VAT and and shipping costs not included. Errors and price changes excepted